help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2005-0574
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Doheny, H. C.
Right arrow Articles by Morrison, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Doheny, H. C.
Right arrow Articles by Morrison, J. J.
Related Collections
Right arrow Female Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 90, No. 10 5786-5796
Copyright © 2005 by The Endocrine Society

Functional Coupling of ß3-Adrenoceptors and Large Conductance Calcium-Activated Potassium Channels in Human Uterine Myocytes

Helen C. Doheny, Caoimhe M. Lynch, Terry J. Smith and John J. Morrison

Department of Obstetrics and Gynecology (H.C.D., C.M.L., J.J.M.), National University of Ireland Galway, Clinical Science Institute, University College Hospital Galway, Galway, Ireland; and National Centre for Biomedical Engineering Science (T.J.S., J.J.M.), National University of Ireland, Galway, Ireland

Address all correspondence and requests for reprints to: Dr. Helen C. Doheny, Department of Obstetrics and Gynecology, National University of Ireland Galway, Clinical Science Institute, University College Hospital Galway, Galway, Ireland. E-mail: hdoheny{at}nuigalway.ie.

Context: ß3-Adrenoreceptor modulation in human myometrium during pregnancy is linked functionally to myometrial inhibition. Maxi-K+ channels (BKCa) play a significant role in modulating cell membrane potential and excitability.

Objective: This study was designed to investigate the potential involvement of BKCa channel function in the response of human myometrium to ß3-adrenoceptor activation.

Design: Single and whole-cell electrophysiological BKCa channel recordings from freshly dispersed myocytes were obtained in the presence and absence of BRL37344, a specific ß3-adrenoreceptor agonist. The in vitro effects of BRL37344 on isolated myometrial contractions, in the presence and absence of the specific BKCa channel blocker, iberiotoxin (IbTX), were investigated.

Setting: The study was carried out at the Clinical Science Institute.

Patients or Other Participants: Myometrial biopsies were obtained at elective cesarean delivery.

Intervention: No intervention was applied.

Main Outcome Measures: Open state probability of single channel recordings, whole cell currents, and myometrial contractile activity were measured.

Results: Single-channel recordings identified the BKCa channel as a target of BRL37344. BRL37344 significantly increased the open state probability of this channel in a concentration-dependent manner (control 0.031 ± 0.004; 50 µM BRL37344 0.073 ± 0.005 (P < 0.001); and 100 µM BRL37344 0.101 ± 0.005 (P < 0.001). This effect was completely blocked after preincubation of the cells with 1 µM bupranolol, a nonspecific ß-adrenoreceptor blocker, or 100 nM SR59230a, a specific ß3-adrenoreceptor antagonist. In addition, BRL37344 increased whole-cell currents over a range of membrane potentials, and this effect was reversed by 100 nM IbTX. In vitro isometric tension studies demonstrated that BRL37344 exerted a significant concentration-dependent relaxant effect on human myometrial tissue (P < 0.05), and preincubation of these strips with IbTX attenuated this effect on both spontaneous and oxytocin-induced contractions (44.44 and 57.84% at 10–5 M, respectively).

Conclusions: These findings outline that activation of the BKCa channel may explain the potent uterorelaxant effect of ß3-adrenoreceptor agonists.




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
K. L. Hristov, X. Cui, S. M. Brown, L. Liu, W. F. Kellett, and G. V. Petkov
Stimulation of {beta}3-adrenoceptors relaxes rat urinary bladder smooth muscle via activation of the large-conductance Ca2+-activated K+ channels
Am J Physiol Cell Physiol, November 1, 2008; 295(5): C1344 - C1353.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. K. Weaver, M. L. Olsen, M. B. McFerrin, and H. Sontheimer
BK Channels Are Linked to Inositol 1,4,5-Triphosphate Receptors via Lipid Rafts: A NOVEL MECHANISM FOR COUPLING [Ca2+]i TO ION CHANNEL ACTIVATION
J. Biol. Chem., October 26, 2007; 282(43): 31558 - 31568.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. Croci, R. Cecchi, P. Marini, C. Rouget, N. Viviani, G. Germain, F. Guagnini, Y. Fradin, L. Descamps, M. Pascal, et al.
In Vitro and in Vivo Pharmacological Characterization of Ethyl-4-{trans-4-[((2S)-2-hydroxy-3-{4-hydroxy-3[(methylsulfonyl)amino]-phenoxy}propyl) Amino]cyclohexyl}benzoate Hydrochloride (SAR150640), a New Potent and Selective Human beta3-Adrenoceptor Agonist for the Treatment of Preterm Labor
J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 1118 - 1126.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. Smith
Parturition
N. Engl. J. Med., January 18, 2007; 356(3): 271 - 283.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society